Completed PHASE2 INTERVENTIONAL 2-arm NCT00217165

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

Taurine as an Anti-manic Agent: a Double-blind Placebo-controlled Study.

Sponsor: Mclean Hospital

Conditions Bipolar Depression Bipolar Disorder Mania

Interventions taurine

Updated 9 times since 2017 Last updated: Feb 26, 2019 Started: Apr 30, 2005 Primary completion: Jan 31, 2010 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Bipolar Depression and Bipolar Disorder, this trial is completed. The trial is conducted by Mclean Hospital and has accumulated 9 data snapshots since 2005. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2
Apr 2019 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jun 2018 — Apr 2019 [monthly]

Completed PHASE2
Apr 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Apr 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mclean Hospital

Data source: Mclean Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belmont, United States